Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
Academic rigor, journalistic flair
Articles on Vaccines
Displaying 241 - 260 of 781 articles
South Africa has clearly suffered the consequences of poor strategic decisions to this point. It doesn’t need to continue along these lines.
At the height of polio and H1N1, Canadians were keen to get vaccinated, but vaccine enthusiasm waned once the crisis had passed — what does that mean for COVID-19?
Should people be compelled to take the vaccine? Should you feel guilty for skipping the line? And what about parts of the world where vaccines aren’t readably available? Ethicists have it covered.
National policies must incorporate good practices derived from lessons learnt so far to strengthen their health systems. Critical policy elements include preparedness and response.
A new network of public clinical trials institutes is urgently needed to replenish the empty pipeline for new antibiotics.
The legal ground in Australia for employers to insist that employees be vaccinated is murky.
Supply chains, choke points, and ‘just in time’ manufacturing – where things went right and wrong during the pandemic.
We often underestimate dangerous risks because they are slow or we think we are in more control of them than we actually are.
Local companies in Africa would find it very challenging to be cost-competitive in the longer run when the current worldwide scarcity of COVID-19 vaccines is overcome.
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
Vaccines have successfully curtailed viral diseases for decades. But as COVID-19 vaccination hesitancy shows, mistrust and misinformation continue to put lives at risk.
Counterfeit vaccines are undermining the global effort to stop COVID-19. Why are they so prevalent, and how can we stop them?
When emergency alerts are hard to distinguish from text messages and when they announce the availability of vaccines rather than an impending tornado, are they still emergency alerts?
The inefficient vaccine allocation rules currently in place must be replaced by new cooperative institutional structures and more concrete steps by the Group of Twenty (G20) countries.
National Cabinet also agreed on a range of other measures, including making the vaccine available to all Australians aged 40-49.
Hundreds of thousands of Canadians got a shot of AstraZeneca’s COVID-19 vaccine for their first dose. They now have a choice for their second dose: AstraZeneca again, or Pfizer or Moderna mRNA vaccine?
New cases have more than doubled in the past two weeks, sparking concerns that last month’s Eid holiday could have been a super-spreader event.
The task now is to turn the reactive response to the health and economic emergencies into a proactive set of policies and actions.
The COVID-19 cases are surging in Nepal, potentially surpassing India’s reproduction rate, but the country is out of vaccines. Global aid could help with one of the worst health crises in South Asia.
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Microbiology, School of Medicine, University of Washington
-
Associate Professor of Biology, Rochester Institute of Technology
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Assistant Professor of Political Science, Oklahoma State University
-
Professor of Immunology, RMIT University
-
Senior Lecturer; MD, Victoria University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
